Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Icosapent Ethyl & Hypertriglyceridemia, Icosapent ethyl has FDA approval for hypertriglyceridemia, and in the EU it is authorized (nationally, not via a central EMA EPAR) for related triglyceride‑lowering/cardiovascular‑risk indications in patients with elevated triglycerides (1, 2).
The clinical phase III trial NCT01492361 demonstrated that among patients with elevated triglyceride levels despite the use of [statins](brain://tEbnIfHO6EeKldlPvre-BA/HMGCoAReductaseHmgcr…